France Attention Deficit Hyperactivity Disorder Market Size & Outlook
France attention deficit hyperactivity disorder market, 2018-2030 (US$M)
Related Markets
France attention deficit hyperactivity disorder market highlights
- The France attention deficit hyperactivity disorder market generated a revenue of USD 263.1 million in 2023 and is expected to reach USD 360.4 million by 2030.
- The France market is expected to grow at a CAGR of 4.6% from 2024 to 2030.
- In terms of segment, stimulants was the largest revenue generating drug type in 2023.
- Non-stimulants is the most lucrative drug type segment registering the fastest growth during the forecast period.
Attention deficit hyperactivity disorder market data book summary
| Market revenue in 2023 | USD 263.1 million |
| Market revenue in 2030 | USD 360.4 million |
| Growth rate | 4.6% (CAGR from 2023 to 2030) |
| Largest segment | Stimulants |
| Fastest growing segment | Non-stimulants |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stimulants, Non-stimulants |
| Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, France accounted for 1.8% of the global attention deficit hyperactivity disorder market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany attention deficit hyperactivity disorder market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 337.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Attention Deficit Hyperactivity Disorder Market Scope
Attention Deficit Hyperactivity Disorder Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France attention deficit hyperactivity disorder market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.
Stimulants was the largest segment with a revenue share of 70.92% in 2023. Horizon Databook has segmented the France attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.
In France, psychiatrists often treat ADHD patients with psychotherapy or family counseling. An increase in the use of additives and preservatives is highly considered for the treatment of behavioral symptoms associated with ADHD. Therefore, France follows a holistic approach by considering a diet, parenting culture, behavioral, and social context for treating children who have ADHD.
The increasing prevalence of attention deficit disorder is anticipated to drive the market. For instance, in France, there were around 2 million people, including children and adults, suffering from the disease. Thus, rising awareness about ADHD and available treatment benefits are expected to increase market penetration.
The ADHD Association and the TypiK'AtypiK Association launched the 1st National ADHD Awareness Day on June 12, 2021, aiming to raise awareness and funding for R&D of novel treatment options to treat patients with ADHD. Furthermore, in France, Methylphenidate (MPH) currently stands as the sole medication approved for the pharmacological treatment of ADHD.
Reasons to subscribe to France attention deficit hyperactivity disorder market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France attention deficit hyperactivity disorder market databook
-
Our clientele includes a mix of attention deficit hyperactivity disorder market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France attention deficit hyperactivity disorder market , including forecasts for subscribers. This country databook contains high-level insights into France attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France attention deficit hyperactivity disorder market size, by drug type, 2018-2030 (US$M)
France Attention Deficit Hyperactivity Disorder Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
